Dutch court rules breast implant manufacturer not liable for illnesses

A Dutch court has ruled that breast implant manufacturer Allergan is not liable for illnesses experienced by women after receiving its implants. The lawsuit was filed by the women’s rights group Bureau Clara Wichmann.

The organization claimed to represent 60,000 women, who could suffer from conditions including autoimmune syndromes, and in some cases, a rare type of lymphoma. Bureau Clara Wichmann argued that the implants were faulty and that Allergan had not adequately informed patients of the associated risks. The group sought compensation for costs incurred, such as those related to implant removal.

The court ruled that there is insufficient evidence linking the implants to autoimmune complaints. While it is recognized that individuals with implants may have experienced symptoms like muscle pain, joint problems, hair loss, and fatigue, the judge cited recent research from Antoni van Leeuwenhoek Hospital, which found that silicone breast implants do not raise the risk of developing such symptoms.

The court acknowledged that individuals with the implants face a higher risk of developing lymphoma, but the precise role of the implants in this risk remains unclear. The judge emphasized that even if a connection exists, it does not necessarily render the product defective.

Like all implants, there are inherent risks, and Allergan had informed doctors accordingly. The judge noted that the presence of such risks does not automatically justify removing the product from the market, as this would also prevent patients from benefiting. When the risk became evident in 2018, Allergan recalled the implants.

Linde Bryk, a lawyer for Bureau Clara Wichmann, described the court’s decision as “a huge blow” for the women involved. It has not yet been decided whether the organization and the affected women will appeal. The bureau stated it is “reviewing legal options to continue pursuing this case.”